Literature DB >> 15538103

Current concepts of pharmacotherapy in hypertension: thiazide-type diuretics: ongoing considerations on mechanism of action.

Domenic A Sica1.   

Abstract

Thiazide-type diuretics have enjoyed a considerable success in the management of hypertension. These drugs have assumed a standard-of-care position in the minds of many health care providers; however, a number of questions remain unresolved in relation to their use. Such questions include issues of mechanism of action, comparability to loop-diuretics in their actions, class-effect, and the basis for their additivity with non-diuretic antihypertensive medication classes. Understanding these issues is important to the effective use of these compounds.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15538103      PMCID: PMC8109655          DOI: 10.1111/j.1524-6175.2004.03902.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  35 in total

1.  Dose-response curves in antihypertensive combination therapy: results of a controlled clinical trial.

Authors:  H Letzel; E Bluemner
Journal:  J Hypertens Suppl       Date:  1990-09

2.  Direct vascular effects of furosemide in humans.

Authors:  P Pickkers; T P Dormans; F G Russel; A D Hughes; T Thien; N Schaper; P Smits
Journal:  Circulation       Date:  1997-09-16       Impact factor: 29.690

3.  Hydrochlorothiazide and verapamil in the treatment of hypertension. The Verapamil Versus Diuretic (VERDI) Trial Research Group.

Authors:  H Holzgreve; A Distler; J Michaelis; T Philipp; S Wellek
Journal:  J Cardiovasc Pharmacol       Date:  1991       Impact factor: 3.105

4.  [The additional efficacy of the nifedipine-diuretic combination depends on the potency of the drug administered first and not the sequence of administration. A double blind study in salt-sensitive black hypertensives].

Authors:  A Damasceno; P Caupers; A Rafik; A Santos; J Polónia
Journal:  Rev Port Cardiol       Date:  1999-01       Impact factor: 1.374

5.  Mechanism of antihypertensive effect of thiazide diuretics.

Authors:  S Shah; I Khatri; E D Freis
Journal:  Am Heart J       Date:  1978-05       Impact factor: 4.749

6.  Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group.

Authors: 
Journal:  JAMA       Date:  1991-06-26       Impact factor: 56.272

7.  Long term reduction in sodium balance: possible additional mechanism whereby nifedipine lowers blood pressure.

Authors:  J B Pevahouse; N D Markandu; F P Cappuccio; M G Buckley; G A Sagnella; G A MacGregor
Journal:  BMJ       Date:  1990-09-22

Review 8.  Hydrochlorothiazide versus chlorthalidone: evidence supporting their interchangeability.

Authors:  Barry L Carter; Michael E Ernst; Jerome D Cohen
Journal:  Hypertension       Date:  2003-11-24       Impact factor: 10.190

9.  Antihypertensive comparison of furosemide with hydrochlorothiazide for black patients.

Authors:  O B Holland; C E Gomez-Sanchez; L V Kuhnert; C Poindexter; C Y Pak
Journal:  Arch Intern Med       Date:  1979-09

10.  A randomized, controlled trial comparing diltiazem, hydrochlorothiazide, and their combination in the therapy of essential hypertension.

Authors:  P E Pool; W B Applegate; T Woehler; P Sandall; W J Cady
Journal:  Pharmacotherapy       Date:  1993 Sep-Oct       Impact factor: 4.705

View more
  3 in total

1.  Resistant hypertension responding to change from furosemide to thiazide: understanding calcium channel blocker-related edema.

Authors:  Joel Handler
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-09-07       Impact factor: 3.738

2.  The effects of angiotensinogen gene polymorphisms on cardiovascular disease outcomes during antihypertensive treatment in the GenHAT study.

Authors:  Anh N Do; Marguerite R Irvin; Amy I Lynch; Steven A Claas; Eric Boerwinkle; Barry R Davis; Charles E Ford; John H Eckfeldt; Hemant K Tiwari; Nita A Limdi; Donna K Arnett
Journal:  Front Pharmacol       Date:  2014-09-16       Impact factor: 5.810

3.  Effects of calcium channel blocker-based combinations on intra-individual blood pressure variability: post hoc analysis of the COPE trial.

Authors:  Seiji Umemoto; Toshio Ogihara; Masunori Matsuzaki; Hiromi Rakugi; Yasuo Ohashi; Takao Saruta
Journal:  Hypertens Res       Date:  2015-10-22       Impact factor: 3.872

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.